Table 1.
Time point | Group | Tulathromycin (ng/ml) |
|
---|---|---|---|
LS meana | 95% CIa | ||
30 min | T-28 | 11,700 | 490–18,500 |
T-7-LPS | 6,790 | 184–11,700 | |
T-7-LPS-CP | 6,700 | 1,230–12,200 | |
T-7 | 3,280 | 1,500–5,070 | |
1 h | T-28 | 792 | 214–1,370 |
T-7-LPS | 3,870 | 713–7,030 | |
T-7-LPS-CP | 6,920 | 1,870–12,000 | |
T-7 | 2,060 | 378–3,700 | |
24 h | T-28 | 145 | 26.7–260 |
T-7-LPS | 50.8 | 13.7–87.9 | |
T-7-LPS-CP | 59.1 | 11.0–107 | |
T-7 | 103 | 28.1–180 | |
48 h | T-28 | 100 | 27.2–174 |
T-7-LPS | 51.1 | 13.8–88.4 | |
T-7-LPS-CP | 57.0 | 15.4–98.6 | |
T-7 | 60.0 | 16.2–103 | |
72 h | T-28 | 109 | 20.2–199 |
T-7-LPS | 19.2 | 5.20–33.2 | |
T-7-LPS-CP | 5.32 | 0.31–10.3 | |
T-7 | 24.4 | 4.50–44.2 | |
96 h | T-28 | 26.2 | 7.10–45.4 |
T-7-LPS | 16.9 | 4.60–29.3 | |
T-7-LPS-CP | 15.9 | 2.93–28.9 | |
T-7 | 9.28 | 2.50–16.0 | |
120 h | T-28 | 19.2 | 3.50–34.9 |
T-o7-LPS | 10.9 | 2.00–19.9 | |
T-7-LPS-CP | 6.89 | 1.27–12.5 | |
T-7 | 10.8 | 2.90–18.7 | |
144 h | T-28 | 13.6 | 3.70–23.5 |
T-7-LPS | 7.82 | 0.50–15.2 | |
T-7-LPS-CP | 6.48 | 1.75–11.2 | |
T-7 | 15.4 | 4.20–26.7 |
Back-transformed.